New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma

xlomafota13 shared this article with you from Inoreader New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma Via Association française pour l'étude du cancer Bull Cancer. 2021 Feb;108(2):139-140. doi: 10.1016/j.bulcan.2020.11.011. Epub 2021 Feb 2. NO ABSTRACT PMID:33546873 | DOI:10.1016/j.bulcan.2020.11.011 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.